Vulnerability in IBM MaaS360 DTM Discloses Sensitive Information
CVE-2017-1422

3.3LOW

Key Information:

Vendor

IBM
Status
Maas360 Dtm
Vendor
CVE Published:
22 August 2017

What is CVE-2017-1422?

IBM MaaS360 DTM prior to version 3.81 is susceptible to a vulnerability that arises from inadequate verification of user permissions associated with certain applications. This oversight may lead to unauthorized access, thereby potentially exposing sensitive user information. Organizations utilizing this software are advised to implement appropriate security measures to mitigate risks associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

MaaS360 DTM 3.81

References

http://www.securityfocus.com/bid/100415
vdb-entryx_refsource_BID
http://www.ibm.com/support/docview.wss?uid=swg22006985
x_refsource_CONFIRM
https://exchange.xforce.ibmcloud.com/vulnerabilities/127412
x_refsource_MISC

CVSS V3.1

Score:
3.3
Severity:
LOW
Confidentiality:
Low
Integrity:
None
Availability:
Low
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.